THYMIC CARCINOMA
Clinical trials for THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare thymus cancers: immune therapy trial
Disease control OngoingThis study is testing whether the immunotherapy drug avelumab is safe and can help control thymoma or thymic carcinoma that has returned or worsened after standard platinum-based chemotherapy. It involves 56 adults who will receive avelumab by IV infusion every two weeks until si…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo aims to shrink tough thymus tumors before surgeons operate
Disease control OngoingThis study tested whether adding the drug cetuximab to standard chemotherapy could better shrink advanced thymoma or thymic carcinoma tumors before surgery. It involved 18 patients with these rare cancers that had not spread to distant organs. The goal was to see if this combinat…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Scientists search for genetic clues in 1000 chest cancer patients
Knowledge-focused ENROLLING_BY_INVITATIONThis research study aims to learn about the biological features of how chest cancers like lung cancer, thymus tumors, and mesothelioma develop and spread. Researchers will analyze blood, tumor tissue, and other fluids from about 1000 patients to look for genetic markers. The goal…
Matched conditions: THYMIC CARCINOMA
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC